BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
147 results:

  • 1. Effect of Esketamine on perioperative anxiety and depression in women with systemic tumors based on big data medical background.
    Wang CH; Lv CY; Lin YF; Zhang WH; Tang XL; Zhao LX
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1797-1811. PubMed ID: 38497863
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
    Leonetti A; Perrone F; Puntoni M; Maglietta G; Bordi P; Bria E; Vita E; Gelsomino F; De Giglio A; Gelibter A; Siringo M; Mazzoni F; Caliman E; Genova C; Bertolini F; Guaitoli G; Passiglia F; Delcuratolo MD; Montrone M; Cerea G; Pasello G; Roca E; Belluomini L; Cecere FL; Guida A; Manzo A; Adamo V; Rastelli F; Bulotta A; Citarella F; Toschi L; Zoratto F; Cortinovis DL; Berardi R; Follador A; Carta A; Camerini A; Salerno F; Silva RR; Baldini E; Cortellini A; Brighenti M; Santoni M; Malorgio F; Caminiti C; Tiseo M
    Eur J Cancer; 2024 May; 202():114006. PubMed ID: 38489861
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
    Mourey L; Rainho LT; Dalban C; Carril-Ajuria L; Negrier S; Chevreau C; Gravis G; Thibault C; Laguerre B; Barthelemy P; Borchiellini D; Gross-Goupil M; Geoffrois L; Rolland F; Thiery-Vuillemin A; Tantot F; Chaput N; Naigeon M; Teixeira M; Escudier B; Flippot R; Albiges L
    Eur J Cancer; 2024 Apr; 201():113589. PubMed ID: 38382153
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparing pyrotinib with trastuzumab and pertuzumab with trastuzumab for HER2-positive metastatic breast cancer: a retrospective, multicenter analysis.
    You S; Xie Y; Sang D; Luo T; Yuan P; Xu F; Wang B
    Front Endocrinol (Lausanne); 2023; 14():1325540. PubMed ID: 38149099
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly.
    Zhang S; Yao S; Chen J; Akter F; Yang J; Zhu D; Zeng A; Chen W; Mao Z; Zhu Y; Wang H
    J Neurosurg; 2024 Apr; 140(4):1019-1028. PubMed ID: 37856412
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nomograms Based on MRI Radiomics for Differential Diagnosis and Predicting BRAFV600E Expression in Pleomorphic Xanthoastrocytoma and Ganglioglioma.
    Kong X; Mao Y; Xi F; Li Y; Luo Y; Ma J
    Acad Radiol; 2024 Mar; 31(3):1069-1081. PubMed ID: 37741731
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
    Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The COP9 signalosome reduces neuroinflammation and attenuates ischemic neuronal stress in organotypic brain slice culture model.
    Tian Y; Milic J; Monasor LS; Chakraborty R; Wang S; Yuan Y; Asare Y; Behrends C; Tahirovic S; Bernhagen J
    Cell Mol Life Sci; 2023 Aug; 80(9):262. PubMed ID: 37597109
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):306-314. PubMed ID: 37144621
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
    de Godoy LL; Chawla S; Brem S; Wang S; O'Rourke DM; Nasrallah MP; Desai A; Loevner LA; Liau LM; Mohan S
    J Neurooncol; 2023 May; 163(1):173-183. PubMed ID: 37129737
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs.
    Chiloiro S; Giampietro A; Gessi M; Lauretti L; Mattogno PP; Cerroni L; Carlino A; De Alessandris QG; Olivi A; Rindi G; Pontecorvi A; De Marinis L; Doglietto F; Bianchi A
    J Neuroendocrinol; 2023 Apr; 35(4):e13263. PubMed ID: 37078422
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Advances and Clinical Trials Update in the treatment of Diffuse Intrinsic Pontine Gliomas.
    Dalle Ore C; Coleman C; Gupta N; Mueller S
    Pediatr Neurosurg; 2023; 58(5):259-266. PubMed ID: 36642062
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: treatment outcome and long-term remission at a single pituitary center.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report.
    Simeni Njonnou SR; Aspeslagh S; Ntsama Essomba MJ; Racu ML; Kemta Lekpa F; Vandergheynst F
    J Med Case Rep; 2022 Dec; 16(1):456. PubMed ID: 36482425
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MR Finding of Extraventricular Neurocytoma.
    Huang S; Liu X; Zhu J; Sun Z; Chen Y; Yu H
    J Coll Physicians Surg Pak; 2022 Nov; 32(11):1478-1482. PubMed ID: 36377019
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Gradual Self-Training via Confidence and Volume Based Domain Adaptation for Multi Dataset Deep Learning-Based brain Metastases Detection Using Nonlocal Networks on MRI Images.
    Liew A; Lee CC; Subramaniam V; Lan BL; Tan M
    J Magn Reson Imaging; 2023 Jun; 57(6):1728-1740. PubMed ID: 36208095
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study.
    Durmuş ET; Atmaca A; Kefeli M; Çalışkan S; Mete O; Aslan K; Fidan M; Çolak R; Durmuş B
    Growth Horm IGF Res; 2022 Dec; 67():101502. PubMed ID: 36115256
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data.
    Jensen LR; Maier AD; Lomstein A; Graillon T; Hrachova M; Bota D; Ruiz-Patiño A; Arrieta O; Cardona AF; Rudà R; Furtner J; Roeckle U; Clement P; Preusser M; Scheie D; Broholm H; Kristensen BW; Skjøth-Rasmussen J; Ziebell M; Munch TN; Fugleholm K; Walter MA; Mathiesen T; Mirian C
    Neurosurg Rev; 2022 Oct; 45(5):3067-3081. PubMed ID: 35984552
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Second line treatment of acromegaly: Pasireotide or Pegvisomant?
    Chiloiro S; Bianchi A; Giampietro A; Pontecorvi A; Raverot G; Marinis L
    Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101684. PubMed ID: 35931640
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Adult brain tumors in Sub-Saharan Africa: A scoping review.
    Kanmounye US; Karekezi C; Nyalundja AD; Awad AK; Laeke T; Balogun JA
    Neuro Oncol; 2022 Oct; 24(10):1799-1806. PubMed ID: 35397473
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.